Neurochemical characterization of receptor-expressing cell populations by in vivo agonist-induced internalization: insights from the somatostatin sst2A receptor.
Characterization of both neurochemical phenotype of G protein-coupled receptor (GPCR)-expressing cells and receptor compartmentalization is a prerequisite for the elucidation of receptor functions in the central nervous system. However, it is often prevented by the diffuse and homogeneous distribution of receptor immunoreactivity. This is particularly true for the somatostatin (SRIF) sst2A receptor, which is largely distributed in the mammalian brain. By using this receptor as a model, we investigated whether receptor internalization, a biochemical property shared by numerous GPCRs, would reveal sst2A-expressing cell populations in the rat dorsolateral septum (LSD), a region in which SRIF might play an important modulatory role. Thirty minutes to 1 hour after intracerebroventricular injection of the sst2A receptor agonist octreotide, numerous sst2A-immunoreactive neurons and processes became apparent due to intracytoplasmic accumulation of intensely stained granules. Double-immunolabeling experiments with synaptophysin and MAP2 provided evidence that internalized sst2A receptors are predominantly localized in the somatodendritic compartment. Revealing sst2A receptor-expressing cell bodies permitted to analyze their neurotransmitter content. Quantitative analysis demonstrated an extensive overlap (approximately 85%) between SRIF- and sst2A-expressing neuronal populations. Additionally, numerous SRIF-immunoreactive axon-like terminals were found in close apposition with sst2A-positive cell bodies and dendrites. Taken together, these data suggest that the sst2A receptor is predominantly expressed in LSD neurons as a postsynaptic autoreceptor, thus providing novel neuroanatomic clues to elucidate SRIF neurotransmission in this region. More generally, in vivo agonist-induced internalization appears as a rapid and powerful tool for the neurochemical characterization of GPCR-expressing cell populations in the mammalian brain.
Csaba
Zsolt
Z
INSERM U549, IFR Broca-Sainte Anne, Centre Paul Broca, 75014 Paris, France.
Simon
Axelle
A
Helboe
Lone
L
Epelbaum
Jacques
J
Dournaud
Pascal
P
D000818:Animals; D001921:Brain / Q000166:cytology* / Q000378:metabolism*; D002451:Cell Compartmentation; D003593:Cytoplasm / Q000378:metabolism; D003594:Cytoplasmic Granules; D006728:Hormones / Q000493:pharmacokinetics; D007276:Injections, Intraventricular; D008297:Male; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D015282:Octreotide / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D017481:Receptors, Somatostatin / Q000378:metabolism*; D013004:Somatostatin / Q000096:biosynthesis*; D016708:Synaptophysin / Q000096:biosynthesis
D006728:Hormones; D008869:Microtubule-Associated Proteins; D017481:Receptors, Somatostatin; D016708:Synaptophysin; C106140:somatostatin receptor sst2A; D013004:Somatostatin; D015282:Octreotide